Sword Health
Sword Health combines AI and clinicians for musculoskeletal, pelvic and mental health care. Latest verified valuation: $4B, 17 June 2025.
Europe's most interesting startup stories. Every week.
No spam. Unsubscribe anytime.
About Sword Health
Sword Health combines AI tools and clinical professionals in remote care programmes for musculoskeletal pain, pelvic health and mental health: Thrive guides the exercises and lets the clinician follow the patient's programme. It sells the programmes to employers, insurers and health systems. It was founded in Portugal in 2015 by Virgílio Bento and Marcio Colunas, launched in the US in January 2020 and now operates through US entities, with a privacy address in New York. Between 2018 and 2025 it raised $364.6M across eight isolated primary rounds, from a $4.6M seed to a $163M Series D on 22 November 2021, up to $40M led by General Catalyst on 17 June 2025. Declared valuations are $2B in 2021 (secondary sale), $3B in 2024 (mixed transaction) and $4B on 17 June 2025, the latest verified; it is a private unicorn with a current value that is not verified. It announced the acquisition of Kaia Health on 28 January 2026 and an agreement for Headspace on 16 September 2026, whose completion is not verified: these are companies bought by Sword, not sales of Sword.
The Story
Sword Health was founded in Portugal in 2015 by Virgílio Bento and Marcio Colunas; its US launch was in January 2020.
Products & Services
Key Products
- Thrive: guida agli esercizi e monitoraggio da parte del clinico
- Programmi per dolore muscoloscheletrico, salute pelvica e salute mentale
- Servizi venduti a datori di lavoro, assicurazioni e sistemi sanitari
Core Use Cases
- Offering employees remote physical therapy
- Cutting health-plan costs through digital care
Market & Clients
Geographic Presence
Funding & Investors
Total Funding
Latest Valuation
Funding Rounds
- 2018 - Seed: $4,6M
- 2019 - Series A: $8M
Lead: Khosla Ventures - 2020 - Estensione Series A: $9M
Lead: Khosla Ventures - 2021 - Series B: $25M
Lead: Transformation Capital - 2021 - Series C: $85M
Lead: General Catalyst - 2021 - Series D: $163M
Lead: Sapphire - 2024 - Round 2024 (quota primaria): $30M
- 2025 - Round 2025: $40M
Lead: General Catalyst
Key Investors
Founding Team
Founders
Key Metrics
Similar Startups
Alan
Health insurer founded in Paris in 2016 and valued by the company at €5.5B on 2 September 2026. It raised €631M of primary capital to 2024, plus 2026 rounds of mixed type.
Read AnalysisIsomorphic Labs
Isomorphic Labs applies advanced AI models — including those underlying AlphaFold — to drug discovery and design, aiming to transform molecular biology into a computational process and radically accelerate therapeutic pipelines.
Read AnalysisLucis
Paris-based preventive healthcare startup analysing 110+ biomarkers and using clinically reviewed AI to guide personalised prevention.
Read AnalysisSources
- Sword — Sword Health
- Terms and Conditions — Sword Health
- Privacy Notice — Sword Health
- Sword timeline (Inc. fastest-growing list) — Sword Health
- Sword Health seed and grant — TechCrunch
- Sword Health raises $8M in Series A — Sword Health (via PR Newswire)
- Sword Health extends Series A to $17M — Sword Health (via PR Newswire)
- Series B announcement — Sword Health
- Sword Health raises $85M Series C — Sword Health (via GlobeNewswire)
- Sword Health closes on $85 million Series C — TechCrunch
- Sword Health raises $163M and reaches $2B valuation — Sword Health
- Sword Health introduces Phoenix and raises $130M — Sword Health (via GlobeNewswire)
- SRS Legal advises Oxy Capital on investment in Sword Health — SRS Legal
- Sword Health raises $40M at a $4B valuation — Sword Health (via GlobeNewswire)
- Kaia Health joins Sword Health — Kaia Health
- Sword acquires Kaia Health — Sword Health (via GlobeNewswire)
- Sword to acquire Headspace — Sword Health